[Federal Register Volume 60, Number 98 (Monday, May 22, 1995)]
[Notices]
[Page 27206]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-12406]
[[Page 27205]]
_______________________________________________________________________
Part IV
Department of Health and Human Services
_______________________________________________________________________
National Institutes of Health
_______________________________________________________________________
Recombinant DNA Advisory Committee: Notice of Meeting; Recombinant DNA
Research: Proposed Actions Under the Guidelines; Notices
Federal Register / Vol. 60, No. 98 / Monday, May 22, 1995 /
Notices
[[Page 27206]]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Recombinant DNA Advisory Committee; Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given of a meeting
of the Recombinant DNA Advisory Committee on June 8-9, 1995. The
meeting will be held at the National Institutes of Health, Building
31C, 6th Floor, Conference Room 6, 9000 Rockville Pike, Bethesda,
Maryland 20892, starting on June 8, 1995, at approximately 9 a.m., and
will recess at approximately 6 p.m. The meeting will reconvene on June
9, 1995, at approximately 8:30 a.m. and will adjourn at approximately 5
p.m. The meeting will be open to the public to discuss Proposed Actions
under the NIH Guidelines for Research Involving Recombinant DNA
Molecules (59 FR 34496) and other matters to be considered by the
Committee. The Proposed Actions to be discussed will follow this notice
of meeting. Attendance by the public will be limited to space
available. Members of the public wishing to speak at this meeting may
be given such opportunity at the discretion of the Chair.
Dr. Nelson A. Wivel, Director, Office of Recombinant DNA
Activities, National Institutes of Health, MSC 7052, 6006 Executive
Boulevard, Suite 323, Bethesda, Maryland 20892-7052, Phone (301) 496-
9838, FAX (301) 496-9839, will provide materials to be discussed at
this meeting, roster of committee members, and substantive program
information. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should contact Dr. Wivel in advance of the meeting. A
summary of the meeting will be available at a later date.
OMB's ``Mandatory Information Requirements for Federal Assistance
Program Announcements'' (45 FR 39592, June 11, 1980) requires a
statement concerning the official government programs contained in the
Catalog of Federal Domestic Assistance. Normally NIH lists in its
announcements the number and title of affected individual programs for
the guidance of the public. Because the guidance in this notice covers
not only virtually every NIH program but also essentially every Federal
research program in which DNA recombinant molecule techniques could be
used, it has been determined not to be cost effective or in the public
interest to attempt to list these programs. Such a list would likely
require several additional pages. In addition, NIH could not be certain
that every Federal program would be included as many Federal agencies,
as well as private organizations, both national and international, have
elected to follow the NIH Guidelines. In lieu of the individual program
listing, NIH invites readers to direct questions to the information
address above about whether individual programs listed in the Catalog
of Federal Domestic Assistance are affected.
Dated: May 15, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-12406 Filed 5-19-95; 8:45 am]
BILLING CODE 4140-01-M
